Hot Pursuit     29-Dec-21
Laurus Labs Ltd spurts 3.57%
Laurus Labs Ltd is quoting at Rs 547.9, up 3.57% on the day as on 12:54 IST on the NSE. The stock is up 56.52% in last one year as compared to a 23.22% spurt in NIFTY and a 9.34% spurt in the Nifty Pharma index.

Laurus Labs Ltd is up for a third straight session in a row. The stock is quoting at Rs 547.9, up 3.57% on the day as on 12:54 IST on the NSE. The benchmark NIFTY is down around 0.03% on the day, quoting at 17228.6. The Sensex is at 57885.29, down 0.02%. Laurus Labs Ltd has risen around 7.72% in last one month.

Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has risen around 2.62% in last one month and is currently quoting at 13836.15, up 1.34% on the day. The volume in the stock stood at 23.64 lakh shares today, compared to the daily average of 17.94 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 547.8, up 3.45% on the day. Laurus Labs Ltd is up 56.52% in last one year as compared to a 23.22% spurt in NIFTY and a 9.34% spurt in the Nifty Pharma index.

The PE of the stock is 29.02 based on TTM earnings ending September 21.

Previous News
  Laurus Labs receives USFDA tentative approval for World's Oral Dispersible Film (ODF) Dolutegravir
 ( Corporate News - 02-May-23   13:49 )
  Laurus Labs
 ( Results - Analysis 28-Jul-23   10:56 )
  Laurus Labs Ltd spurts 0.92%, rises for fifth straight session
 ( Hot Pursuit - 11-Oct-23   13:00 )
  Laurus Labs update on acquisition of further stake in lmmunoACT
 ( Corporate News - 12-Jul-23   18:23 )
  Laurus Labs Ltd up for third consecutive session
 ( Hot Pursuit - 10-Dec-21   13:05 )
  Laurus Labs announces board meeting date
 ( Corporate News - 25-Oct-21   09:22 )
  Laurus Labs Q2 PAT slides 17% YoY to Rs 202 cr
 ( Hot Pursuit - 28-Oct-21   16:17 )
  Laurus Labs announces resignation of director
 ( Corporate News - 29-Feb-20   12:06 )
  Laurus Labs Ltd up for third consecutive session
 ( Hot Pursuit - 07-Jun-24   13:05 )
  Laurus Labs receives USFDA approval for two ANDA's TLE 400 & TLE 600 tablets
 ( Corporate News - 19-May-20   16:45 )
  Laurus Labs standalone net profit rises 42.09% in the June 2017 quarter
 ( Results - Announcements 11-Aug-17   16:32 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top